KYOWA KIRIN AND KNIGHT THERAPEUTICS ENTER INTO EXCLUSIVE DISTRIBUTION AGREEMENT FOR POTELIGEO® (MOGAMULIZUMAB) FOR CUTANEOUS T-CELL LYMPHOMA (CTCL) PATIENTS ACROSS LATIN AMERICA

Reuters · 2d ago

Please log in to view news